TCL Archive GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile August 30, 2013
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds August 26, 2005
TCL Archive “Of Sofas and Chairs” at MD Anderson: Official Seeks Protection from “Losers,” Explains Costly Interior Design Choices June 7, 2013
TCL Archive Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says January 20, 1995
